DZ Bank Knock-Out AMGN/ DE000DJ5SZU1 /
10/07/2024 21:36:42 | Chg.- | Bid08:03:17 | Ask08:03:17 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.63EUR | - | 4.46 Bid Size: 500 |
4.48 Ask Size: 500 |
Amgen Inc | 368.7921 USD | 31/12/2078 | Put |
GlobeNewswire
27/06
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire
27/06
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire
25/06
Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
GlobeNewswire
20/06
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
19/06
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire
18/06
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire
17/06
FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire
17/06
Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire
30/05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
28/05
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
27/05
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
23/05
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire
22/05
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire
21/05
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update